Almac Clinical Services, a subsidiary of Almac Group, has introduced its Tempod 1000 that is claimed to enhance the company's Site Compliance and temperature management offering for sponsors, it was reported on Wednesday.
Intended to augment Almac's established temperature management service, Tempod 1000 is a USB device that captures and stores all clinical site temperature data and automatically finds unreported excursions once uploaded into TempEZ. It is aimed at removing the administrative burden of updating manual temperature logs, increasing site compliance with reporting data and promoting best digital practice in clinical studies and patient safety.
The device will also decrease the risk of missed patient visits due to unreported excursions, enable sponsors and CRAs to identify and resolve excursions remotely, accelerates CRA review time during site visits, and facilitate timely and efficient study close-outs and database locks.
Airiver medical receives FDA approval for central airway stenosis trial
Talphera reaches enrollment milestone in NEPHRO CRRT pivotal trial
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
Covalon Technologies secures DTC eligibility to expand US investor access
Navamedic ASA secures final approvals for Flexilev in OraFID across Nordic markets
Oncopeptides partners with SD Pharma to expand Pepaxti access in Spain
Aptar launches bio-based nasal spray pump with Haleon's Otrivin brand
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Alcon to acquire LumiThera and its FDA-authorised photobiomodulation device for dry AMD treatment
Predictmedix AI launches mobile diabetes screening platform in India
Navamedic's medical device OraFID approved as primary package for a pharmaceutical product
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions